Follow us on Twitter
Tuesday, July 16, 2013
Healthcare costs caused by improper and unnecessary use of medicines exceeded $200 billion in 2012, according to a recently released IMS Institute for Healthcare Informatics report. This session details the primary areas of avoidable costs and details two specific areas that account for more than two-thirds of avoidable costs. Join us to learn how payers and providers employ IMS’s data-driven approach to provide critical insight into, a) medicine non-adherence and improved medication management, b) evidence-based views of treatment delays that lead to spending progression, and c) advanced data and analytics to holistically improve patient outcomes in quality and cost across both pharma and medical benefit. Hear more about how impartial, longitudinally linked, patient-centered data can deliver timely insights to reduce wasteful variations in care, identify care gaps, and ultimately advance PCMHs and ACOs as mechanisms to improve medication use.